222 related articles for article (PubMed ID: 22196854)
1. Emerging cellular targets for influenza antiviral agents.
Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
[TBL] [Abstract][Full Text] [Related]
2. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
An L; Liu R; Tang W; Wu JG; Chen X
Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of strictinin on influenza virus replication.
Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
[TBL] [Abstract][Full Text] [Related]
4. Antivirals for influenza: historical perspectives and lessons learned.
Hayden FG
Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
[TBL] [Abstract][Full Text] [Related]
6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus.
Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K
Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin A1 inhibits avian influenza virus replication at a postentry level: Effect on virus protein synthesis and NF-κB activity.
Carta S; La Frazia S; Donatelli I; Puzelli S; Rossi A; Santoro MG
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):311-23. PubMed ID: 25151089
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors against influenza virus.
Rajik M; Yusoff K
Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
[TBL] [Abstract][Full Text] [Related]
11. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
12. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
13. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
Chen SC; Jeng KS; Lai MMC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
[TBL] [Abstract][Full Text] [Related]
14. [The substances active against influenza virus. Possibilities and prospects of application].
Kwiatek M; Kocik J; Bartoszcze M
Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
[TBL] [Abstract][Full Text] [Related]
15. The promise of siRNAs for the treatment of influenza.
Bennink JR; Palmore TN
Trends Mol Med; 2004 Dec; 10(12):571-4. PubMed ID: 15567323
[TBL] [Abstract][Full Text] [Related]
16. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
[TBL] [Abstract][Full Text] [Related]
17. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.
Fu Y; Gaelings L; Söderholm S; Belanov S; Nandania J; Nyman TA; Matikainen S; Anders S; Velagapudi V; Kainov DE
Antiviral Res; 2016 Sep; 133():23-31. PubMed ID: 27451344
[TBL] [Abstract][Full Text] [Related]
18. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics.
Ulyanova V; Shah Mahmud R; Laikov A; Dudkina E; Markelova M; Mostafa A; Pleschka S; Ilinskaya O
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167434
[TBL] [Abstract][Full Text] [Related]
19. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
20. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
